While the development of renal denervation technologies stalled after a failed Medtronic study in 2014, recent positive research results have led to increasing interest - and investment - in the space.
A medical device company run by serial entrepreneur David Fischell has raised $1.4 million for the development of its catheter system to treat hypertension. The fundraising target for the series A round is $2.5 million, according to a Form D filing with the U.S. Securities and Exchange Commission. David Fischell is the co-founder of and […]
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.